Abstract
Huang O, Zhang W, Zhi Q, Xue X, Liu H, Shen D, Geng M, Xie Z, Jiang M. Teriflunomide, an immunomodulatory drug, exerts anticancer activity in triple negative breast cancer cells. Exp Biol Med (Maywood). 2015;240(4):426–437.
In this article the image for DMSO-treated BT549 cells in Figure 5 was incorrect. The correct image/figure is shown below.
